Minnesota HF3756 amends the insulin safety net program, defining covered insulin and establishing manufacturer responsibilities and registration fees.

Minnesota HF3756 amends the insulin safety net program by defining "covered insulin" as a drug containing insulin for treating diabetes, excluding insulin products with a wholesale acquisition cost of $8 or less per milliliter. The bill mandates that manufacturers establish procedures to provide covered insulin to eligible individuals in urgent need or seeking affordable supplies. Manufacturers must maintain privacy of application data and are prohibited from selling or sharing it without consent.

Minnesota HF3756 amends the insulin safety net program, defining covered insulin and establishing manufacturer responsibilities and registration fees.

Minnesota HF3756 amends the insulin safety net program by defining "covered insulin" as a drug containing insulin for treating diabetes, excluding insulin products with a wholesale acquisition cost of $8 or less per milliliter. The bill mandates that manufacturers establish procedures to provide covered insulin to eligible individuals in urgent need or seeking affordable supplies. Manufacturers must maintain privacy of application data and are prohibited from selling or sharing it without consent.